# Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers

> **NCT02268773** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Asasantin®
- **DRUG:** Acetylsalicylic acid low dose
- **DRUG:** Acetylsalicylic acid high dose

## Key facts

- **NCT ID:** NCT02268773
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2000-05
- **Final completion:** —
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2014-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02268773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02268773, "Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02268773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*